High-dose DFMO alters protein translation in neuroblastoma
Andrea T. Franson, Kangning Liu, Rohan Vemu, Elizabeth W. Scadden, Yimei Li, Annette T. Vu, Michael D. Hogarty
This paper evaluates how high-dose DFMO affects protein translation in neuroblastoma, showing it inhibits translation at high doses but not low doses, suggesting potential for higher-dose therapies.
Neoplasia · Aug 6, 2025Peer-reviewedCancer Biology